nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2C19—coronary artery disease	0.158	1	CbGaD
Cyclophosphamide—CYP2C8—Fenofibrate—coronary artery disease	0.0166	0.0278	CbGbCtD
Cyclophosphamide—CYP2B6—Clopidogrel—coronary artery disease	0.0152	0.0254	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0148	0.0248	CbGbCtD
Cyclophosphamide—CYP3A7—Eplerenone—coronary artery disease	0.0148	0.0248	CbGbCtD
Cyclophosphamide—CYP2C8—Gemfibrozil—coronary artery disease	0.0133	0.0222	CbGbCtD
Cyclophosphamide—ABCB1—Ticagrelor—coronary artery disease	0.0126	0.0211	CbGbCtD
Cyclophosphamide—CYP3A5—Clopidogrel—coronary artery disease	0.012	0.02	CbGbCtD
Cyclophosphamide—CYP2C9—Fenofibrate—coronary artery disease	0.0116	0.0194	CbGbCtD
Cyclophosphamide—CYP2C8—Clopidogrel—coronary artery disease	0.0115	0.0193	CbGbCtD
Cyclophosphamide—CYP2C19—Gemfibrozil—coronary artery disease	0.0111	0.0186	CbGbCtD
Cyclophosphamide—CYP3A5—Eplerenone—coronary artery disease	0.0111	0.0186	CbGbCtD
Cyclophosphamide—CYP2C8—Pitavastatin—coronary artery disease	0.0101	0.0168	CbGbCtD
Cyclophosphamide—CYP2C19—Clopidogrel—coronary artery disease	0.00966	0.0162	CbGbCtD
Cyclophosphamide—CYP3A7—Simvastatin—coronary artery disease	0.00956	0.016	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00956	0.016	CbGbCtD
Cyclophosphamide—CYP3A7—Lovastatin—coronary artery disease	0.00936	0.0157	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00936	0.0157	CbGbCtD
Cyclophosphamide—CYP2C9—Gemfibrozil—coronary artery disease	0.00926	0.0155	CbGbCtD
Cyclophosphamide—CYP2B6—Simvastatin—coronary artery disease	0.00911	0.0152	CbGbCtD
Cyclophosphamide—CYP3A7—Atorvastatin—coronary artery disease	0.00852	0.0143	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00852	0.0143	CbGbCtD
Cyclophosphamide—CYP2C19—Telmisartan—coronary artery disease	0.00844	0.0141	CbGbCtD
Cyclophosphamide—CYP2B6—Atorvastatin—coronary artery disease	0.00812	0.0136	CbGbCtD
Cyclophosphamide—CYP2C9—Clopidogrel—coronary artery disease	0.00803	0.0134	CbGbCtD
Cyclophosphamide—ABCB1—Clopidogrel—coronary artery disease	0.00779	0.013	CbGbCtD
Cyclophosphamide—ABCB1—Perindopril—coronary artery disease	0.00779	0.013	CbGbCtD
Cyclophosphamide—CYP3A5—Rosuvastatin—coronary artery disease	0.00772	0.0129	CbGbCtD
Cyclophosphamide—CYP3A4—Ticagrelor—coronary artery disease	0.00756	0.0126	CbGbCtD
Cyclophosphamide—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00723	0.0121	CbGbCtD
Cyclophosphamide—CYP3A5—Simvastatin—coronary artery disease	0.00717	0.012	CbGbCtD
Cyclophosphamide—CYP3A5—Pravastatin—coronary artery disease	0.00702	0.0117	CbGbCtD
Cyclophosphamide—CYP3A5—Lovastatin—coronary artery disease	0.00702	0.0117	CbGbCtD
Cyclophosphamide—CYP2C9—Pitavastatin—coronary artery disease	0.00702	0.0117	CbGbCtD
Cyclophosphamide—CYP2C8—Simvastatin—coronary artery disease	0.0069	0.0115	CbGbCtD
Cyclophosphamide—CYP2C9—Valsartan—coronary artery disease	0.00683	0.0114	CbGbCtD
Cyclophosphamide—ABCB1—Pitavastatin—coronary artery disease	0.00681	0.0114	CbGbCtD
Cyclophosphamide—ABCB1—Telmisartan—coronary artery disease	0.00681	0.0114	CbGbCtD
Cyclophosphamide—CYP2C19—Timolol—coronary artery disease	0.00681	0.0114	CbGbCtD
Cyclophosphamide—CYP2C8—Pravastatin—coronary artery disease	0.00675	0.0113	CbGbCtD
Cyclophosphamide—CYP2C8—Lovastatin—coronary artery disease	0.00675	0.0113	CbGbCtD
Cyclophosphamide—CYP3A4—Fenofibrate—coronary artery disease	0.00674	0.0113	CbGbCtD
Cyclophosphamide—ABCB1—Enalapril—coronary artery disease	0.00646	0.0108	CbGbCtD
Cyclophosphamide—ABCB1—Lisinopril—coronary artery disease	0.00646	0.0108	CbGbCtD
Cyclophosphamide—CYP3A5—Atorvastatin—coronary artery disease	0.00639	0.0107	CbGbCtD
Cyclophosphamide—CYP2C19—Rosuvastatin—coronary artery disease	0.00622	0.0104	CbGbCtD
Cyclophosphamide—CYP2C8—Atorvastatin—coronary artery disease	0.00615	0.0103	CbGbCtD
Cyclophosphamide—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00607	0.0101	CbGbCtD
Cyclophosphamide—CYP3A5—Losartan—coronary artery disease	0.00585	0.00978	CbGbCtD
Cyclophosphamide—CYP2C19—Simvastatin—coronary artery disease	0.00579	0.00968	CbGbCtD
Cyclophosphamide—CYP2C19—Lovastatin—coronary artery disease	0.00566	0.00947	CbGbCtD
Cyclophosphamide—CYP2C8—Losartan—coronary artery disease	0.00562	0.00941	CbGbCtD
Cyclophosphamide—CYP2D6—Niacin—coronary artery disease	0.00557	0.00931	CbGbCtD
Cyclophosphamide—ABCB1—Timolol—coronary artery disease	0.00549	0.00919	CbGbCtD
Cyclophosphamide—CYP3A4—Gemfibrozil—coronary artery disease	0.00539	0.00901	CbGbCtD
Cyclophosphamide—CYP2C9—Rosuvastatin—coronary artery disease	0.00517	0.00866	CbGbCtD
Cyclophosphamide—CYP2D6—Timolol—coronary artery disease	0.00517	0.00866	CbGbCtD
Cyclophosphamide—CYP2C19—Atorvastatin—coronary artery disease	0.00516	0.00863	CbGbCtD
Cyclophosphamide—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00504	0.00844	CbGbCtD
Cyclophosphamide—ABCB1—Ezetimibe—coronary artery disease	0.00502	0.0084	CbGbCtD
Cyclophosphamide—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00489	0.00819	CbGbCtD
Cyclophosphamide—ABCB1—Captopril—coronary artery disease	0.00483	0.00809	CbGbCtD
Cyclophosphamide—CYP2C9—Simvastatin—coronary artery disease	0.00481	0.00805	CbGbCtD
Cyclophosphamide—CYP2C19—Losartan—coronary artery disease	0.00472	0.00789	CbGbCtD
Cyclophosphamide—CYP2C9—Lovastatin—coronary artery disease	0.00471	0.00788	CbGbCtD
Cyclophosphamide—CYP2C9—Pravastatin—coronary artery disease	0.00471	0.00788	CbGbCtD
Cyclophosphamide—CYP3A4—Clopidogrel—coronary artery disease	0.00467	0.00781	CbGbCtD
Cyclophosphamide—ABCB1—Simvastatin—coronary artery disease	0.00467	0.00781	CbGbCtD
Cyclophosphamide—ABCB1—Pravastatin—coronary artery disease	0.00457	0.00764	CbGbCtD
Cyclophosphamide—ABCB1—Lovastatin—coronary artery disease	0.00457	0.00764	CbGbCtD
Cyclophosphamide—CYP2D6—Captopril—coronary artery disease	0.00456	0.00762	CbGbCtD
Cyclophosphamide—CYP2D6—Simvastatin—coronary artery disease	0.0044	0.00736	CbGbCtD
Cyclophosphamide—CYP3A4—Eplerenone—coronary artery disease	0.00434	0.00726	CbGbCtD
Cyclophosphamide—CYP2D6—Pravastatin—coronary artery disease	0.00431	0.0072	CbGbCtD
Cyclophosphamide—CYP2D6—Lovastatin—coronary artery disease	0.00431	0.0072	CbGbCtD
Cyclophosphamide—CYP2C9—Atorvastatin—coronary artery disease	0.00429	0.00717	CbGbCtD
Cyclophosphamide—ABCB1—Atorvastatin—coronary artery disease	0.00416	0.00696	CbGbCtD
Cyclophosphamide—CYP2C9—Losartan—coronary artery disease	0.00392	0.00656	CbGbCtD
Cyclophosphamide—CYP2D6—Atorvastatin—coronary artery disease	0.00392	0.00656	CbGbCtD
Cyclophosphamide—CYP3A4—Enalapril—coronary artery disease	0.00387	0.00647	CbGbCtD
Cyclophosphamide—ABCB1—Losartan—coronary artery disease	0.00381	0.00637	CbGbCtD
Cyclophosphamide—CYP3A4—Rosuvastatin—coronary artery disease	0.00301	0.00503	CbGbCtD
Cyclophosphamide—CYP3A4—Ezetimibe—coronary artery disease	0.00301	0.00503	CbGbCtD
Cyclophosphamide—CYP3A4—Simvastatin—coronary artery disease	0.0028	0.00468	CbGbCtD
Cyclophosphamide—CYP3A4—Pravastatin—coronary artery disease	0.00274	0.00458	CbGbCtD
Cyclophosphamide—CYP3A4—Lovastatin—coronary artery disease	0.00274	0.00458	CbGbCtD
Cyclophosphamide—CYP3A4—Atorvastatin—coronary artery disease	0.00249	0.00417	CbGbCtD
Cyclophosphamide—CYP3A4—Losartan—coronary artery disease	0.00228	0.00381	CbGbCtD
Cyclophosphamide—Ifosfamide—CYP2C19—coronary artery disease	0.000785	1	CrCbGaD
Cyclophosphamide—Vomiting—Lovastatin—coronary artery disease	4.22e-05	0.000225	CcSEcCtD
Cyclophosphamide—Dizziness—Eplerenone—coronary artery disease	4.21e-05	0.000224	CcSEcCtD
Cyclophosphamide—Rash—Clopidogrel—coronary artery disease	4.21e-05	0.000224	CcSEcCtD
Cyclophosphamide—Dermatitis—Clopidogrel—coronary artery disease	4.21e-05	0.000224	CcSEcCtD
Cyclophosphamide—Asthenia—Valsartan—coronary artery disease	4.21e-05	0.000224	CcSEcCtD
Cyclophosphamide—Hypertension—Timolol—coronary artery disease	4.21e-05	0.000224	CcSEcCtD
Cyclophosphamide—Pain—Furosemide—coronary artery disease	4.2e-05	0.000224	CcSEcCtD
Cyclophosphamide—Constipation—Furosemide—coronary artery disease	4.2e-05	0.000224	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Niacin—coronary artery disease	4.2e-05	0.000224	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Lisinopril—coronary artery disease	4.19e-05	0.000223	CcSEcCtD
Cyclophosphamide—Discomfort—Ramipril—coronary artery disease	4.19e-05	0.000223	CcSEcCtD
Cyclophosphamide—Asthenia—Olmesartan—coronary artery disease	4.19e-05	0.000223	CcSEcCtD
Cyclophosphamide—Headache—Clopidogrel—coronary artery disease	4.19e-05	0.000223	CcSEcCtD
Cyclophosphamide—Rash—Lovastatin—coronary artery disease	4.19e-05	0.000223	CcSEcCtD
Cyclophosphamide—Dermatitis—Lovastatin—coronary artery disease	4.18e-05	0.000223	CcSEcCtD
Cyclophosphamide—Anaemia—Lisinopril—coronary artery disease	4.18e-05	0.000222	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Perindopril—coronary artery disease	4.17e-05	0.000222	CcSEcCtD
Cyclophosphamide—Headache—Lovastatin—coronary artery disease	4.16e-05	0.000221	CcSEcCtD
Cyclophosphamide—Pruritus—Valsartan—coronary artery disease	4.15e-05	0.000221	CcSEcCtD
Cyclophosphamide—Arthralgia—Timolol—coronary artery disease	4.15e-05	0.000221	CcSEcCtD
Cyclophosphamide—Myalgia—Timolol—coronary artery disease	4.15e-05	0.000221	CcSEcCtD
Cyclophosphamide—Chest pain—Timolol—coronary artery disease	4.15e-05	0.000221	CcSEcCtD
Cyclophosphamide—Vomiting—Ezetimibe—coronary artery disease	4.14e-05	0.00022	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Pravastatin—coronary artery disease	4.14e-05	0.00022	CcSEcCtD
Cyclophosphamide—Pruritus—Olmesartan—coronary artery disease	4.13e-05	0.00022	CcSEcCtD
Cyclophosphamide—Decreased appetite—Losartan—coronary artery disease	4.12e-05	0.000219	CcSEcCtD
Cyclophosphamide—Body temperature increased—Captopril—coronary artery disease	4.12e-05	0.000219	CcSEcCtD
Cyclophosphamide—Dizziness—Simvastatin—coronary artery disease	4.11e-05	0.000219	CcSEcCtD
Cyclophosphamide—Rash—Ezetimibe—coronary artery disease	4.11e-05	0.000219	CcSEcCtD
Cyclophosphamide—Dermatitis—Ezetimibe—coronary artery disease	4.1e-05	0.000218	CcSEcCtD
Cyclophosphamide—Confusional state—Ramipril—coronary artery disease	4.1e-05	0.000218	CcSEcCtD
Cyclophosphamide—Discomfort—Timolol—coronary artery disease	4.1e-05	0.000218	CcSEcCtD
Cyclophosphamide—Asthenia—Niacin—coronary artery disease	4.09e-05	0.000218	CcSEcCtD
Cyclophosphamide—Fatigue—Losartan—coronary artery disease	4.09e-05	0.000218	CcSEcCtD
Cyclophosphamide—Headache—Ezetimibe—coronary artery disease	4.08e-05	0.000217	CcSEcCtD
Cyclophosphamide—Malaise—Lisinopril—coronary artery disease	4.07e-05	0.000217	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Ramipril—coronary artery disease	4.07e-05	0.000217	CcSEcCtD
Cyclophosphamide—Oedema—Ramipril—coronary artery disease	4.07e-05	0.000217	CcSEcCtD
Cyclophosphamide—Pain—Losartan—coronary artery disease	4.06e-05	0.000216	CcSEcCtD
Cyclophosphamide—Constipation—Losartan—coronary artery disease	4.06e-05	0.000216	CcSEcCtD
Cyclophosphamide—Vomiting—Eplerenone—coronary artery disease	4.05e-05	0.000216	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Furosemide—coronary artery disease	4.05e-05	0.000216	CcSEcCtD
Cyclophosphamide—Leukopenia—Lisinopril—coronary artery disease	4.04e-05	0.000215	CcSEcCtD
Cyclophosphamide—Nausea—Fenofibrate—coronary artery disease	4.04e-05	0.000215	CcSEcCtD
Cyclophosphamide—Pruritus—Niacin—coronary artery disease	4.03e-05	0.000215	CcSEcCtD
Cyclophosphamide—Asthenia—Pravastatin—coronary artery disease	4.03e-05	0.000214	CcSEcCtD
Cyclophosphamide—Rash—Eplerenone—coronary artery disease	4.02e-05	0.000214	CcSEcCtD
Cyclophosphamide—Urticaria—Perindopril—coronary artery disease	4.02e-05	0.000214	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Trandolapril—coronary artery disease	4.02e-05	0.000214	CcSEcCtD
Cyclophosphamide—Dermatitis—Eplerenone—coronary artery disease	4.01e-05	0.000214	CcSEcCtD
Cyclophosphamide—Diarrhoea—Valsartan—coronary artery disease	4.01e-05	0.000214	CcSEcCtD
Cyclophosphamide—Confusional state—Timolol—coronary artery disease	4.01e-05	0.000213	CcSEcCtD
Cyclophosphamide—Shock—Ramipril—coronary artery disease	4e-05	0.000213	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Enalapril—coronary artery disease	4e-05	0.000213	CcSEcCtD
Cyclophosphamide—Body temperature increased—Perindopril—coronary artery disease	4e-05	0.000213	CcSEcCtD
Cyclophosphamide—Palpitations—Lisinopril—coronary artery disease	3.99e-05	0.000213	CcSEcCtD
Cyclophosphamide—Diarrhoea—Olmesartan—coronary artery disease	3.99e-05	0.000213	CcSEcCtD
Cyclophosphamide—Headache—Eplerenone—coronary artery disease	3.99e-05	0.000213	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Ramipril—coronary artery disease	3.98e-05	0.000212	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Timolol—coronary artery disease	3.98e-05	0.000212	CcSEcCtD
Cyclophosphamide—Oedema—Timolol—coronary artery disease	3.98e-05	0.000212	CcSEcCtD
Cyclophosphamide—Pruritus—Pravastatin—coronary artery disease	3.97e-05	0.000211	CcSEcCtD
Cyclophosphamide—Nausea—Clopidogrel—coronary artery disease	3.97e-05	0.000211	CcSEcCtD
Cyclophosphamide—Tachycardia—Ramipril—coronary artery disease	3.97e-05	0.000211	CcSEcCtD
Cyclophosphamide—Infection—Timolol—coronary artery disease	3.95e-05	0.00021	CcSEcCtD
Cyclophosphamide—Vomiting—Simvastatin—coronary artery disease	3.95e-05	0.00021	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Telmisartan—coronary artery disease	3.95e-05	0.00021	CcSEcCtD
Cyclophosphamide—Cough—Lisinopril—coronary artery disease	3.94e-05	0.00021	CcSEcCtD
Cyclophosphamide—Nausea—Lovastatin—coronary artery disease	3.94e-05	0.00021	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Ramipril—coronary artery disease	3.93e-05	0.000209	CcSEcCtD
Cyclophosphamide—Rash—Simvastatin—coronary artery disease	3.91e-05	0.000208	CcSEcCtD
Cyclophosphamide—Dermatitis—Simvastatin—coronary artery disease	3.91e-05	0.000208	CcSEcCtD
Cyclophosphamide—Asthenia—Trandolapril—coronary artery disease	3.91e-05	0.000208	CcSEcCtD
Cyclophosphamide—Shock—Timolol—coronary artery disease	3.91e-05	0.000208	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Losartan—coronary artery disease	3.91e-05	0.000208	CcSEcCtD
Cyclophosphamide—Urticaria—Furosemide—coronary artery disease	3.9e-05	0.000208	CcSEcCtD
Cyclophosphamide—Diarrhoea—Niacin—coronary artery disease	3.9e-05	0.000208	CcSEcCtD
Cyclophosphamide—Asthenia—Enalapril—coronary artery disease	3.9e-05	0.000207	CcSEcCtD
Cyclophosphamide—Headache—Simvastatin—coronary artery disease	3.89e-05	0.000207	CcSEcCtD
Cyclophosphamide—Body temperature increased—Furosemide—coronary artery disease	3.89e-05	0.000207	CcSEcCtD
Cyclophosphamide—Dizziness—Valsartan—coronary artery disease	3.88e-05	0.000206	CcSEcCtD
Cyclophosphamide—Anorexia—Ramipril—coronary artery disease	3.88e-05	0.000206	CcSEcCtD
Cyclophosphamide—Nausea—Ezetimibe—coronary artery disease	3.87e-05	0.000206	CcSEcCtD
Cyclophosphamide—Dizziness—Olmesartan—coronary artery disease	3.86e-05	0.000205	CcSEcCtD
Cyclophosphamide—Pruritus—Trandolapril—coronary artery disease	3.86e-05	0.000205	CcSEcCtD
Cyclophosphamide—Myalgia—Lisinopril—coronary artery disease	3.85e-05	0.000205	CcSEcCtD
Cyclophosphamide—Chest pain—Lisinopril—coronary artery disease	3.85e-05	0.000205	CcSEcCtD
Cyclophosphamide—Arthralgia—Lisinopril—coronary artery disease	3.85e-05	0.000205	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Timolol—coronary artery disease	3.84e-05	0.000205	CcSEcCtD
Cyclophosphamide—Asthenia—Telmisartan—coronary artery disease	3.84e-05	0.000205	CcSEcCtD
Cyclophosphamide—Pruritus—Enalapril—coronary artery disease	3.84e-05	0.000205	CcSEcCtD
Cyclophosphamide—Diarrhoea—Pravastatin—coronary artery disease	3.84e-05	0.000204	CcSEcCtD
Cyclophosphamide—Discomfort—Lisinopril—coronary artery disease	3.8e-05	0.000202	CcSEcCtD
Cyclophosphamide—Hypotension—Ramipril—coronary artery disease	3.8e-05	0.000202	CcSEcCtD
Cyclophosphamide—Anorexia—Timolol—coronary artery disease	3.79e-05	0.000202	CcSEcCtD
Cyclophosphamide—Pruritus—Telmisartan—coronary artery disease	3.79e-05	0.000202	CcSEcCtD
Cyclophosphamide—Nausea—Eplerenone—coronary artery disease	3.79e-05	0.000202	CcSEcCtD
Cyclophosphamide—Dizziness—Niacin—coronary artery disease	3.77e-05	0.000201	CcSEcCtD
Cyclophosphamide—Urticaria—Losartan—coronary artery disease	3.77e-05	0.000201	CcSEcCtD
Cyclophosphamide—Body temperature increased—Losartan—coronary artery disease	3.75e-05	0.0002	CcSEcCtD
Cyclophosphamide—Asthenia—Captopril—coronary artery disease	3.74e-05	0.000199	CcSEcCtD
Cyclophosphamide—Diarrhoea—Trandolapril—coronary artery disease	3.73e-05	0.000199	CcSEcCtD
Cyclophosphamide—Vomiting—Valsartan—coronary artery disease	3.73e-05	0.000199	CcSEcCtD
Cyclophosphamide—Confusional state—Lisinopril—coronary artery disease	3.72e-05	0.000198	CcSEcCtD
Cyclophosphamide—Diarrhoea—Enalapril—coronary artery disease	3.71e-05	0.000198	CcSEcCtD
Cyclophosphamide—Hypotension—Timolol—coronary artery disease	3.71e-05	0.000198	CcSEcCtD
Cyclophosphamide—Dizziness—Pravastatin—coronary artery disease	3.71e-05	0.000198	CcSEcCtD
Cyclophosphamide—Vomiting—Olmesartan—coronary artery disease	3.71e-05	0.000198	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.7e-05	0.000197	CcSEcCtD
Cyclophosphamide—Rash—Valsartan—coronary artery disease	3.7e-05	0.000197	CcSEcCtD
Cyclophosphamide—Dermatitis—Valsartan—coronary artery disease	3.69e-05	0.000197	CcSEcCtD
Cyclophosphamide—Nausea—Simvastatin—coronary artery disease	3.69e-05	0.000196	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Lisinopril—coronary artery disease	3.69e-05	0.000196	CcSEcCtD
Cyclophosphamide—Oedema—Lisinopril—coronary artery disease	3.69e-05	0.000196	CcSEcCtD
Cyclophosphamide—Pruritus—Captopril—coronary artery disease	3.68e-05	0.000196	CcSEcCtD
Cyclophosphamide—Rash—Olmesartan—coronary artery disease	3.68e-05	0.000196	CcSEcCtD
Cyclophosphamide—Dermatitis—Olmesartan—coronary artery disease	3.68e-05	0.000196	CcSEcCtD
Cyclophosphamide—Headache—Valsartan—coronary artery disease	3.67e-05	0.000196	CcSEcCtD
Cyclophosphamide—Diarrhoea—Telmisartan—coronary artery disease	3.66e-05	0.000195	CcSEcCtD
Cyclophosphamide—Infection—Lisinopril—coronary artery disease	3.66e-05	0.000195	CcSEcCtD
Cyclophosphamide—Headache—Olmesartan—coronary artery disease	3.66e-05	0.000195	CcSEcCtD
Cyclophosphamide—Paraesthesia—Ramipril—coronary artery disease	3.65e-05	0.000194	CcSEcCtD
Cyclophosphamide—Shock—Lisinopril—coronary artery disease	3.63e-05	0.000193	CcSEcCtD
Cyclophosphamide—Asthenia—Perindopril—coronary artery disease	3.63e-05	0.000193	CcSEcCtD
Cyclophosphamide—Dyspnoea—Ramipril—coronary artery disease	3.63e-05	0.000193	CcSEcCtD
Cyclophosphamide—Vomiting—Niacin—coronary artery disease	3.63e-05	0.000193	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Timolol—coronary artery disease	3.62e-05	0.000193	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Furosemide—coronary artery disease	3.62e-05	0.000193	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Lisinopril—coronary artery disease	3.61e-05	0.000192	CcSEcCtD
Cyclophosphamide—Dizziness—Trandolapril—coronary artery disease	3.6e-05	0.000192	CcSEcCtD
Cyclophosphamide—Tachycardia—Lisinopril—coronary artery disease	3.6e-05	0.000192	CcSEcCtD
Cyclophosphamide—Rash—Niacin—coronary artery disease	3.59e-05	0.000191	CcSEcCtD
Cyclophosphamide—Dermatitis—Niacin—coronary artery disease	3.59e-05	0.000191	CcSEcCtD
Cyclophosphamide—Dizziness—Enalapril—coronary artery disease	3.59e-05	0.000191	CcSEcCtD
Cyclophosphamide—Pruritus—Perindopril—coronary artery disease	3.58e-05	0.00019	CcSEcCtD
Cyclophosphamide—Headache—Niacin—coronary artery disease	3.57e-05	0.00019	CcSEcCtD
Cyclophosphamide—Paraesthesia—Timolol—coronary artery disease	3.57e-05	0.00019	CcSEcCtD
Cyclophosphamide—Vomiting—Pravastatin—coronary artery disease	3.57e-05	0.00019	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Lisinopril—coronary artery disease	3.57e-05	0.00019	CcSEcCtD
Cyclophosphamide—Diarrhoea—Captopril—coronary artery disease	3.56e-05	0.00019	CcSEcCtD
Cyclophosphamide—Dyspnoea—Timolol—coronary artery disease	3.54e-05	0.000189	CcSEcCtD
Cyclophosphamide—Dizziness—Telmisartan—coronary artery disease	3.54e-05	0.000189	CcSEcCtD
Cyclophosphamide—Rash—Pravastatin—coronary artery disease	3.54e-05	0.000188	CcSEcCtD
Cyclophosphamide—Dermatitis—Pravastatin—coronary artery disease	3.54e-05	0.000188	CcSEcCtD
Cyclophosphamide—Decreased appetite—Ramipril—coronary artery disease	3.53e-05	0.000188	CcSEcCtD
Cyclophosphamide—Asthenia—Furosemide—coronary artery disease	3.53e-05	0.000188	CcSEcCtD
Cyclophosphamide—Headache—Pravastatin—coronary artery disease	3.52e-05	0.000187	CcSEcCtD
Cyclophosphamide—Anorexia—Lisinopril—coronary artery disease	3.52e-05	0.000187	CcSEcCtD
Cyclophosphamide—Fatigue—Ramipril—coronary artery disease	3.51e-05	0.000187	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Losartan—coronary artery disease	3.49e-05	0.000186	CcSEcCtD
Cyclophosphamide—Nausea—Valsartan—coronary artery disease	3.48e-05	0.000185	CcSEcCtD
Cyclophosphamide—Pruritus—Furosemide—coronary artery disease	3.48e-05	0.000185	CcSEcCtD
Cyclophosphamide—Constipation—Ramipril—coronary artery disease	3.48e-05	0.000185	CcSEcCtD
Cyclophosphamide—Nausea—Olmesartan—coronary artery disease	3.47e-05	0.000185	CcSEcCtD
Cyclophosphamide—Vomiting—Trandolapril—coronary artery disease	3.47e-05	0.000185	CcSEcCtD
Cyclophosphamide—Diarrhoea—Perindopril—coronary artery disease	3.46e-05	0.000184	CcSEcCtD
Cyclophosphamide—Decreased appetite—Timolol—coronary artery disease	3.46e-05	0.000184	CcSEcCtD
Cyclophosphamide—Vomiting—Enalapril—coronary artery disease	3.45e-05	0.000184	CcSEcCtD
Cyclophosphamide—Hypotension—Lisinopril—coronary artery disease	3.45e-05	0.000183	CcSEcCtD
Cyclophosphamide—Dizziness—Captopril—coronary artery disease	3.44e-05	0.000183	CcSEcCtD
Cyclophosphamide—Rash—Trandolapril—coronary artery disease	3.44e-05	0.000183	CcSEcCtD
Cyclophosphamide—Dermatitis—Trandolapril—coronary artery disease	3.43e-05	0.000183	CcSEcCtD
Cyclophosphamide—Fatigue—Timolol—coronary artery disease	3.43e-05	0.000182	CcSEcCtD
Cyclophosphamide—Rash—Enalapril—coronary artery disease	3.42e-05	0.000182	CcSEcCtD
Cyclophosphamide—Dermatitis—Enalapril—coronary artery disease	3.42e-05	0.000182	CcSEcCtD
Cyclophosphamide—Headache—Trandolapril—coronary artery disease	3.42e-05	0.000182	CcSEcCtD
Cyclophosphamide—Vomiting—Telmisartan—coronary artery disease	3.4e-05	0.000181	CcSEcCtD
Cyclophosphamide—Asthenia—Losartan—coronary artery disease	3.4e-05	0.000181	CcSEcCtD
Cyclophosphamide—Headache—Enalapril—coronary artery disease	3.4e-05	0.000181	CcSEcCtD
Cyclophosphamide—Pain—Timolol—coronary artery disease	3.4e-05	0.000181	CcSEcCtD
Cyclophosphamide—Nausea—Niacin—coronary artery disease	3.39e-05	0.00018	CcSEcCtD
Cyclophosphamide—Rash—Telmisartan—coronary artery disease	3.38e-05	0.00018	CcSEcCtD
Cyclophosphamide—Dermatitis—Telmisartan—coronary artery disease	3.37e-05	0.00018	CcSEcCtD
Cyclophosphamide—Diarrhoea—Furosemide—coronary artery disease	3.36e-05	0.000179	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.36e-05	0.000179	CcSEcCtD
Cyclophosphamide—Pruritus—Losartan—coronary artery disease	3.36e-05	0.000179	CcSEcCtD
Cyclophosphamide—Headache—Telmisartan—coronary artery disease	3.35e-05	0.000179	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Ramipril—coronary artery disease	3.35e-05	0.000178	CcSEcCtD
Cyclophosphamide—Dizziness—Perindopril—coronary artery disease	3.34e-05	0.000178	CcSEcCtD
Cyclophosphamide—Nausea—Pravastatin—coronary artery disease	3.33e-05	0.000178	CcSEcCtD
Cyclophosphamide—Paraesthesia—Lisinopril—coronary artery disease	3.31e-05	0.000176	CcSEcCtD
Cyclophosphamide—Vomiting—Captopril—coronary artery disease	3.31e-05	0.000176	CcSEcCtD
Cyclophosphamide—Dyspnoea—Lisinopril—coronary artery disease	3.29e-05	0.000175	CcSEcCtD
Cyclophosphamide—Rash—Captopril—coronary artery disease	3.28e-05	0.000175	CcSEcCtD
Cyclophosphamide—Dermatitis—Captopril—coronary artery disease	3.28e-05	0.000175	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Timolol—coronary artery disease	3.28e-05	0.000174	CcSEcCtD
Cyclophosphamide—Headache—Captopril—coronary artery disease	3.26e-05	0.000174	CcSEcCtD
Cyclophosphamide—Dizziness—Furosemide—coronary artery disease	3.25e-05	0.000173	CcSEcCtD
Cyclophosphamide—Diarrhoea—Losartan—coronary artery disease	3.24e-05	0.000173	CcSEcCtD
Cyclophosphamide—Nausea—Trandolapril—coronary artery disease	3.24e-05	0.000172	CcSEcCtD
Cyclophosphamide—Urticaria—Ramipril—coronary artery disease	3.23e-05	0.000172	CcSEcCtD
Cyclophosphamide—Nausea—Enalapril—coronary artery disease	3.23e-05	0.000172	CcSEcCtD
Cyclophosphamide—Vomiting—Perindopril—coronary artery disease	3.21e-05	0.000171	CcSEcCtD
Cyclophosphamide—Body temperature increased—Ramipril—coronary artery disease	3.21e-05	0.000171	CcSEcCtD
Cyclophosphamide—Decreased appetite—Lisinopril—coronary artery disease	3.21e-05	0.000171	CcSEcCtD
Cyclophosphamide—Rash—Perindopril—coronary artery disease	3.19e-05	0.00017	CcSEcCtD
Cyclophosphamide—Dermatitis—Perindopril—coronary artery disease	3.18e-05	0.00017	CcSEcCtD
Cyclophosphamide—Nausea—Telmisartan—coronary artery disease	3.18e-05	0.000169	CcSEcCtD
Cyclophosphamide—Fatigue—Lisinopril—coronary artery disease	3.18e-05	0.000169	CcSEcCtD
Cyclophosphamide—Headache—Perindopril—coronary artery disease	3.17e-05	0.000169	CcSEcCtD
Cyclophosphamide—Urticaria—Timolol—coronary artery disease	3.16e-05	0.000168	CcSEcCtD
Cyclophosphamide—Pain—Lisinopril—coronary artery disease	3.15e-05	0.000168	CcSEcCtD
Cyclophosphamide—Constipation—Lisinopril—coronary artery disease	3.15e-05	0.000168	CcSEcCtD
Cyclophosphamide—Body temperature increased—Timolol—coronary artery disease	3.14e-05	0.000167	CcSEcCtD
Cyclophosphamide—Dizziness—Losartan—coronary artery disease	3.14e-05	0.000167	CcSEcCtD
Cyclophosphamide—Vomiting—Furosemide—coronary artery disease	3.13e-05	0.000166	CcSEcCtD
Cyclophosphamide—Rash—Furosemide—coronary artery disease	3.1e-05	0.000165	CcSEcCtD
Cyclophosphamide—Dermatitis—Furosemide—coronary artery disease	3.1e-05	0.000165	CcSEcCtD
Cyclophosphamide—Nausea—Captopril—coronary artery disease	3.09e-05	0.000165	CcSEcCtD
Cyclophosphamide—Headache—Furosemide—coronary artery disease	3.08e-05	0.000164	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Lisinopril—coronary artery disease	3.04e-05	0.000162	CcSEcCtD
Cyclophosphamide—Vomiting—Losartan—coronary artery disease	3.02e-05	0.000161	CcSEcCtD
Cyclophosphamide—Nausea—Perindopril—coronary artery disease	3e-05	0.00016	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Ramipril—coronary artery disease	3e-05	0.00016	CcSEcCtD
Cyclophosphamide—Rash—Losartan—coronary artery disease	2.99e-05	0.000159	CcSEcCtD
Cyclophosphamide—Dermatitis—Losartan—coronary artery disease	2.99e-05	0.000159	CcSEcCtD
Cyclophosphamide—Headache—Losartan—coronary artery disease	2.97e-05	0.000158	CcSEcCtD
Cyclophosphamide—Urticaria—Lisinopril—coronary artery disease	2.93e-05	0.000156	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Timolol—coronary artery disease	2.93e-05	0.000156	CcSEcCtD
Cyclophosphamide—Nausea—Furosemide—coronary artery disease	2.92e-05	0.000155	CcSEcCtD
Cyclophosphamide—Asthenia—Ramipril—coronary artery disease	2.92e-05	0.000155	CcSEcCtD
Cyclophosphamide—Body temperature increased—Lisinopril—coronary artery disease	2.92e-05	0.000155	CcSEcCtD
Cyclophosphamide—Pruritus—Ramipril—coronary artery disease	2.88e-05	0.000153	CcSEcCtD
Cyclophosphamide—Asthenia—Timolol—coronary artery disease	2.85e-05	0.000152	CcSEcCtD
Cyclophosphamide—Nausea—Losartan—coronary artery disease	2.82e-05	0.00015	CcSEcCtD
Cyclophosphamide—Pruritus—Timolol—coronary artery disease	2.81e-05	0.00015	CcSEcCtD
Cyclophosphamide—Diarrhoea—Ramipril—coronary artery disease	2.78e-05	0.000148	CcSEcCtD
Cyclophosphamide—Diarrhoea—Timolol—coronary artery disease	2.72e-05	0.000145	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Lisinopril—coronary artery disease	2.72e-05	0.000145	CcSEcCtD
Cyclophosphamide—Dizziness—Ramipril—coronary artery disease	2.69e-05	0.000143	CcSEcCtD
Cyclophosphamide—Asthenia—Lisinopril—coronary artery disease	2.65e-05	0.000141	CcSEcCtD
Cyclophosphamide—Dizziness—Timolol—coronary artery disease	2.63e-05	0.00014	CcSEcCtD
Cyclophosphamide—Pruritus—Lisinopril—coronary artery disease	2.61e-05	0.000139	CcSEcCtD
Cyclophosphamide—Vomiting—Ramipril—coronary artery disease	2.59e-05	0.000138	CcSEcCtD
Cyclophosphamide—Rash—Ramipril—coronary artery disease	2.56e-05	0.000137	CcSEcCtD
Cyclophosphamide—Dermatitis—Ramipril—coronary artery disease	2.56e-05	0.000136	CcSEcCtD
Cyclophosphamide—Headache—Ramipril—coronary artery disease	2.55e-05	0.000136	CcSEcCtD
Cyclophosphamide—Vomiting—Timolol—coronary artery disease	2.53e-05	0.000135	CcSEcCtD
Cyclophosphamide—Diarrhoea—Lisinopril—coronary artery disease	2.52e-05	0.000134	CcSEcCtD
Cyclophosphamide—Rash—Timolol—coronary artery disease	2.51e-05	0.000133	CcSEcCtD
Cyclophosphamide—Dermatitis—Timolol—coronary artery disease	2.5e-05	0.000133	CcSEcCtD
Cyclophosphamide—Headache—Timolol—coronary artery disease	2.49e-05	0.000133	CcSEcCtD
Cyclophosphamide—Dizziness—Lisinopril—coronary artery disease	2.44e-05	0.00013	CcSEcCtD
Cyclophosphamide—Nausea—Ramipril—coronary artery disease	2.42e-05	0.000129	CcSEcCtD
Cyclophosphamide—Nausea—Timolol—coronary artery disease	2.36e-05	0.000126	CcSEcCtD
Cyclophosphamide—Vomiting—Lisinopril—coronary artery disease	2.34e-05	0.000125	CcSEcCtD
Cyclophosphamide—Rash—Lisinopril—coronary artery disease	2.33e-05	0.000124	CcSEcCtD
Cyclophosphamide—Dermatitis—Lisinopril—coronary artery disease	2.32e-05	0.000124	CcSEcCtD
Cyclophosphamide—Headache—Lisinopril—coronary artery disease	2.31e-05	0.000123	CcSEcCtD
Cyclophosphamide—Nausea—Lisinopril—coronary artery disease	2.19e-05	0.000117	CcSEcCtD
Cyclophosphamide—CYP2A6—Metabolism—APOE—coronary artery disease	3.83e-06	6.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.82e-06	6.82e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HADH—coronary artery disease	3.82e-06	6.82e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	3.81e-06	6.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—APOA1—coronary artery disease	3.79e-06	6.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PSMB5—coronary artery disease	3.78e-06	6.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PSMA6—coronary artery disease	3.78e-06	6.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOB—coronary artery disease	3.77e-06	6.74e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTM1—coronary artery disease	3.76e-06	6.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PSMA6—coronary artery disease	3.75e-06	6.7e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PSMB5—coronary artery disease	3.75e-06	6.7e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.75e-06	6.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CTGF—coronary artery disease	3.7e-06	6.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—LPL—coronary artery disease	3.69e-06	6.58e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTM1—coronary artery disease	3.67e-06	6.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CTGF—coronary artery disease	3.67e-06	6.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—HMGCR—coronary artery disease	3.66e-06	6.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GOT2—coronary artery disease	3.66e-06	6.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PLCB1—coronary artery disease	3.66e-06	6.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PPARG—coronary artery disease	3.64e-06	6.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GOT2—coronary artery disease	3.63e-06	6.49e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—HMGCR—coronary artery disease	3.63e-06	6.49e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOA2—coronary artery disease	3.62e-06	6.47e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.62e-06	6.47e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GPX2—coronary artery disease	3.62e-06	6.47e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—LPL—coronary artery disease	3.6e-06	6.43e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GPX1—coronary artery disease	3.6e-06	6.42e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.59e-06	6.42e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—POMC—coronary artery disease	3.59e-06	6.41e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GPX4—coronary artery disease	3.58e-06	6.39e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HK1—coronary artery disease	3.58e-06	6.39e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.58e-06	6.39e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.58e-06	6.39e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PLCB1—coronary artery disease	3.58e-06	6.38e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ABCA1—coronary artery disease	3.55e-06	6.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HADHA—coronary artery disease	3.54e-06	6.31e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GPX1—coronary artery disease	3.52e-06	6.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CD36—coronary artery disease	3.5e-06	6.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.5e-06	6.24e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ABCA1—coronary artery disease	3.47e-06	6.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTP1—coronary artery disease	3.46e-06	6.18e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPP2CA—coronary artery disease	3.46e-06	6.18e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LPA—coronary artery disease	3.46e-06	6.17e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GGT1—coronary artery disease	3.44e-06	6.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GOT1—coronary artery disease	3.44e-06	6.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	3.43e-06	6.12e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CD36—coronary artery disease	3.42e-06	6.11e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—HMOX1—coronary artery disease	3.41e-06	6.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPP2CA—coronary artery disease	3.38e-06	6.04e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.37e-06	6.02e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CAT—coronary artery disease	3.37e-06	6.01e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GGT1—coronary artery disease	3.36e-06	5.99e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GOT1—coronary artery disease	3.36e-06	5.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.35e-06	5.98e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.34e-06	5.96e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PPARG—coronary artery disease	3.34e-06	5.96e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—MTHFR—coronary artery disease	3.32e-06	5.93e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOA5—coronary artery disease	3.31e-06	5.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—POMC—coronary artery disease	3.29e-06	5.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.28e-06	5.85e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ALB—coronary artery disease	3.27e-06	5.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOB—coronary artery disease	3.27e-06	5.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.27e-06	5.83e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—P4HB—coronary artery disease	3.25e-06	5.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—MTHFR—coronary artery disease	3.25e-06	5.79e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ABCA1—coronary artery disease	3.24e-06	5.78e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.19e-06	5.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTM1—coronary artery disease	3.18e-06	5.68e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GGT1—coronary artery disease	3.16e-06	5.65e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GOT1—coronary artery disease	3.16e-06	5.65e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AGT—coronary artery disease	3.15e-06	5.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GGT1—coronary artery disease	3.14e-06	5.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GOT1—coronary artery disease	3.14e-06	5.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—NOS3—coronary artery disease	3.13e-06	5.59e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—LPL—coronary artery disease	3.12e-06	5.57e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—APOE—coronary artery disease	3.09e-06	5.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTP1—coronary artery disease	3.09e-06	5.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AGT—coronary artery disease	3.08e-06	5.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	3.06e-06	5.46e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—APOA1—coronary artery disease	3.06e-06	5.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—HMOX1—coronary artery disease	3.05e-06	5.44e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GPX1—coronary artery disease	3.05e-06	5.44e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOE—coronary artery disease	3.02e-06	5.39e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTP1—coronary artery disease	3.02e-06	5.38e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—VCAN—coronary artery disease	3.01e-06	5.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CAT—coronary artery disease	3.01e-06	5.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ALB—coronary artery disease	3e-06	5.36e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.99e-06	5.33e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOA1—coronary artery disease	2.99e-06	5.33e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.98e-06	5.33e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—HMOX1—coronary artery disease	2.97e-06	5.31e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CD36—coronary artery disease	2.97e-06	5.3e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CAT—coronary artery disease	2.93e-06	5.24e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPP2CA—coronary artery disease	2.93e-06	5.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOB—coronary artery disease	2.92e-06	5.21e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—DCN—coronary artery disease	2.9e-06	5.17e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—NOS3—coronary artery disease	2.87e-06	5.12e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—coronary artery disease	2.86e-06	5.11e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOB—coronary artery disease	2.85e-06	5.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.84e-06	5.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTM1—coronary artery disease	2.84e-06	5.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.82e-06	5.03e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.82e-06	5.03e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.81e-06	5.03e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—MTHFR—coronary artery disease	2.81e-06	5.02e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.8e-06	5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.79e-06	4.98e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—LPL—coronary artery disease	2.79e-06	4.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.78e-06	4.96e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTM1—coronary artery disease	2.77e-06	4.95e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CAT—coronary artery disease	2.76e-06	4.94e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HBA1—coronary artery disease	2.75e-06	4.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LIPC—coronary artery disease	2.75e-06	4.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.75e-06	4.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.75e-06	4.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CAT—coronary artery disease	2.74e-06	4.89e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOC3—coronary artery disease	2.73e-06	4.87e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—LPL—coronary artery disease	2.72e-06	4.86e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GPX1—coronary artery disease	2.72e-06	4.85e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LDLR—coronary artery disease	2.71e-06	4.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPARG—coronary artery disease	2.69e-06	4.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOB—coronary artery disease	2.68e-06	4.79e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.68e-06	4.78e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.68e-06	4.78e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AGT—coronary artery disease	2.67e-06	4.77e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOB—coronary artery disease	2.66e-06	4.75e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—POMC—coronary artery disease	2.66e-06	4.74e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GPX1—coronary artery disease	2.65e-06	4.74e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CA—coronary artery disease	2.65e-06	4.73e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CETP—coronary artery disease	2.65e-06	4.73e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GCLC—coronary artery disease	2.65e-06	4.73e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CD36—coronary artery disease	2.65e-06	4.73e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPARG—coronary artery disease	2.63e-06	4.7e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—coronary artery disease	2.62e-06	4.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SDC1—coronary artery disease	2.62e-06	4.68e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOE—coronary artery disease	2.62e-06	4.67e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.61e-06	4.67e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.61e-06	4.66e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—POMC—coronary artery disease	2.6e-06	4.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.59e-06	4.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOA1—coronary artery disease	2.59e-06	4.62e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CD36—coronary artery disease	2.58e-06	4.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—LPL—coronary artery disease	2.56e-06	4.58e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.55e-06	4.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—LPL—coronary artery disease	2.54e-06	4.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—MTHFR—coronary artery disease	2.51e-06	4.48e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GPX1—coronary artery disease	2.5e-06	4.46e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GPX1—coronary artery disease	2.48e-06	4.43e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.48e-06	4.42e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.47e-06	4.42e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.47e-06	4.42e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—MTHFR—coronary artery disease	2.45e-06	4.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CD36—coronary artery disease	2.44e-06	4.35e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ALB—coronary artery disease	2.42e-06	4.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CTGF—coronary artery disease	2.42e-06	4.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CD36—coronary artery disease	2.41e-06	4.31e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.4e-06	4.29e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.4e-06	4.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GOT2—coronary artery disease	2.4e-06	4.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.38e-06	4.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AGT—coronary artery disease	2.38e-06	4.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ALB—coronary artery disease	2.37e-06	4.22e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOE—coronary artery disease	2.34e-06	4.17e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AGT—coronary artery disease	2.33e-06	4.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—NOS3—coronary artery disease	2.32e-06	4.13e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOA1—coronary artery disease	2.31e-06	4.12e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.31e-06	4.12e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.29e-06	4.08e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOE—coronary artery disease	2.28e-06	4.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARG—coronary artery disease	2.28e-06	4.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—NOS3—coronary artery disease	2.26e-06	4.04e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOA1—coronary artery disease	2.25e-06	4.02e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—POMC—coronary artery disease	2.25e-06	4.01e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.21e-06	3.95e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.2e-06	3.93e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AGT—coronary artery disease	2.19e-06	3.91e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AGT—coronary artery disease	2.17e-06	3.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—AKT1—coronary artery disease	2.16e-06	3.87e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOE—coronary artery disease	2.15e-06	3.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.14e-06	3.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOE—coronary artery disease	2.13e-06	3.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOA1—coronary artery disease	2.12e-06	3.79e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—coronary artery disease	2.12e-06	3.78e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOA1—coronary artery disease	2.11e-06	3.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—coronary artery disease	2.07e-06	3.7e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GGT1—coronary artery disease	2.07e-06	3.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GOT1—coronary artery disease	2.07e-06	3.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALB—coronary artery disease	2.05e-06	3.66e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARG—coronary artery disease	2.03e-06	3.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.02e-06	3.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—POMC—coronary artery disease	2.01e-06	3.58e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARG—coronary artery disease	1.99e-06	3.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—NOS3—coronary artery disease	1.96e-06	3.5e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—POMC—coronary artery disease	1.96e-06	3.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARG—coronary artery disease	1.87e-06	3.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.86e-06	3.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARG—coronary artery disease	1.86e-06	3.31e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—POMC—coronary artery disease	1.85e-06	3.29e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.84e-06	3.29e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.83e-06	3.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—POMC—coronary artery disease	1.83e-06	3.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALB—coronary artery disease	1.83e-06	3.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CAT—coronary artery disease	1.81e-06	3.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—coronary artery disease	1.79e-06	3.2e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALB—coronary artery disease	1.79e-06	3.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CA—coronary artery disease	1.76e-06	3.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOB—coronary artery disease	1.75e-06	3.13e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—NOS3—coronary artery disease	1.75e-06	3.12e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NOS3—coronary artery disease	1.71e-06	3.05e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.71e-06	3.05e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALB—coronary artery disease	1.68e-06	3e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LPL—coronary artery disease	1.68e-06	2.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALB—coronary artery disease	1.67e-06	2.98e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GPX1—coronary artery disease	1.63e-06	2.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CA—coronary artery disease	1.61e-06	2.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NOS3—coronary artery disease	1.61e-06	2.87e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.6e-06	2.86e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NOS3—coronary artery disease	1.6e-06	2.85e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CD36—coronary artery disease	1.59e-06	2.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.57e-06	2.81e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—coronary artery disease	1.56e-06	2.79e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.51e-06	2.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.47e-06	2.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.46e-06	2.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—AKT1—coronary artery disease	1.44e-06	2.57e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AGT—coronary artery disease	1.43e-06	2.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOE—coronary artery disease	1.4e-06	2.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOA1—coronary artery disease	1.39e-06	2.48e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—AKT1—coronary artery disease	1.32e-06	2.36e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CA—coronary artery disease	1.3e-06	2.33e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.27e-06	2.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARG—coronary artery disease	1.22e-06	2.18e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—POMC—coronary artery disease	1.21e-06	2.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.1e-06	1.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALB—coronary artery disease	1.1e-06	1.96e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AKT1—coronary artery disease	1.06e-06	1.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NOS3—coronary artery disease	1.05e-06	1.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AKT1—coronary artery disease	1.04e-06	1.86e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CA—coronary artery disease	9.85e-07	1.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—coronary artery disease	9.62e-07	1.72e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CA—coronary artery disease	9.61e-07	1.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CA—coronary artery disease	9.06e-07	1.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AKT1—coronary artery disease	9.01e-07	1.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CA—coronary artery disease	8.98e-07	1.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AKT1—coronary artery disease	8.04e-07	1.44e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AKT1—coronary artery disease	7.85e-07	1.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AKT1—coronary artery disease	7.4e-07	1.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AKT1—coronary artery disease	7.33e-07	1.31e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.92e-07	1.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AKT1—coronary artery disease	4.84e-07	8.64e-06	CbGpPWpGaD
